KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NexPoint Residential Trust (NXRT) Gains from Sales and Divestitures (2016 - 2025)

NexPoint Residential Trust (NXRT) has disclosed Gains from Sales and Divestitures for 10 consecutive years, with $395594.0 as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 47.56% to $395594.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $395594.0, a 47.56% decrease, with the full-year FY2025 number at $395594.0, down 47.56% from a year prior.
  • Gains from Sales and Divestitures was $395594.0 for Q4 2025 at NexPoint Residential Trust, up from $82861.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $754329.0 in Q4 2024 to a low of $22017.0 in Q3 2021.
  • A 5-year average of $128210.8 and a median of $74422.5 in 2022 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: plummeted 87.64% in 2021, then soared 1472.14% in 2024.
  • NexPoint Residential Trust's Gains from Sales and Divestitures stood at $22017.0 in 2021, then surged by 199.7% to $65984.0 in 2022, then decreased by 27.28% to $47981.0 in 2023, then skyrocketed by 1472.14% to $754329.0 in 2024, then tumbled by 47.56% to $395594.0 in 2025.
  • Per Business Quant, the three most recent readings for NXRT's Gains from Sales and Divestitures are $395594.0 (Q4 2025), $82861.0 (Q3 2025), and $112622.0 (Q2 2025).